Chemed Co. (NYSE:CHE) Stock Position Cut by Hengehold Capital Management LLC

Hengehold Capital Management LLC decreased its stake in shares of Chemed Co. (NYSE:CHEFree Report) by 52.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 454 shares of the company’s stock after selling 491 shares during the period. Hengehold Capital Management LLC’s holdings in Chemed were worth $240,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. UMB Bank n.a. increased its stake in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after acquiring an additional 39 shares during the period. Trust Co. of Vermont acquired a new position in shares of Chemed during the 4th quarter valued at $34,000. American National Bank & Trust bought a new stake in shares of Chemed in the 3rd quarter worth $61,000. GAMMA Investing LLC raised its stake in shares of Chemed by 60.5% in the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after buying an additional 52 shares in the last quarter. Finally, Quarry LP boosted its stake in Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after buying an additional 166 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have commented on CHE. Royal Bank of Canada dropped their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

View Our Latest Stock Analysis on CHE

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company’s stock.

Chemed Stock Up 1.7 %

Shares of NYSE CHE opened at $550.99 on Friday. The business has a fifty day simple moving average of $544.24 and a 200-day simple moving average of $562.98. The company has a market cap of $8.29 billion, a price-to-earnings ratio of 27.84, a P/E/G ratio of 2.15 and a beta of 0.47. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $654.62.

Chemed (NYSE:CHEGet Free Report) last announced its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.32 earnings per share. As a group, sell-side analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.